< Back to Article

COVID-19 cross-sectional study in Maricá, Brazil: The impact of vaccination coverage on viral incidence

Fig 2

Percentage of anti-SCOV2 immunoglobulin positivity in each study cycle.

A, B and C) Anti-SCOV2 Immunoglobulin profile of unvaccinated participants. A) All vaccinated participants. B) <60 years old group. C) ≥60 years old group. White bars represent the 1^st cycle, grey bars the 2^nd cycle and black bars the 3^rd cycle.

doi: https://doi.org/10.1371/journal.pone.0269011.g002